A Comment on Coronavirus Disease 2019 and the Hair

    January 2024 in “ International Journal of Trichology ”
    Hudson Dutra Rezende, Maria Fernanda Reis Gavazzoni Dias, Antonia Régnier … Ralph M. Trüeb
    Studysummary In this study, researchers reviewed the evidence linking COVID-19 with dermatologic conditions like androgenetic alopecia and concluded that most proposed associations lack convincing statistical support, challenging the idea of these as independent risk factors for COVID-19 severity.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 21

    1. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    2. Comment on: The Gabrin Sign Journal of The American Academy of Dermatology · 2020
    3. Alopecia and Grey Hair Are Associated with COVID-19 Severity Experimental Dermatology · 2020
    4. Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients Journal of the European Academy of Dermatology and Venereology · 2020
    5. Acute Telogen Effluvium Associated with SARS-CoV-2 Infection AJGP · 2020
    6. Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19' Journal of The American Academy of Dermatology · 2020
    7. Androgenetic Alopecia in COVID-19: Compared to What? Journal of The American Academy of Dermatology · 2020
    8. Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign Journal of The American Academy of Dermatology · 2020
    9. Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications Dermatologic Therapy · 2020
    10. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    11. Androgen Sensitivity Gateway to COVID-19 Disease Severity Drug Development Research · 2020
    12. Effects of 5-Alpha Reductase Inhibitors on Lung Function: A Reason for Discontinuation During COVID-19 Pandemic? Dermatologic Therapy · 2020
    13. Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19? Journal of Cosmetic Dermatology · 2020
    14. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    15. What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy Dermatologic Therapy · 2020
    16. Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells Frontiers in Cellular and Infection Microbiology · 2018
    17. Telogen Effluvium: Is There a Need for a New Classification Skin appendage disorders · 2016
    18. Hair Growth Inhibition by Psychoemotional Stress: A Mouse Model for Neural Mechanisms in Hair Growth Control Experimental Dermatology · 2005
    19. Is Baldness Bad for the Heart? Dermatology · 2005
    20. Personality Disorders and Psychopathologic Symptoms in Patients With Androgenetic Alopecia Archives of Dermatology · 1994
    21. Telogen Effluvium: A Comprehensive Review Archives of Dermatology · 1993